LabCompass

Susan Tsai

Medicine · The Ohio State University

Established · publishing since 1995Rising activity

Publications

18

Citations

127

Est. group size

Recurring co-author estimate

Active years

31

Publishing since 1995

Research summary
AI-generated

Susan Tsai's research focuses on the clinical management and treatment of pancreatic cancer, including staging, neoadjuvant (pre-surgery) therapy, radiation planning, and biomarkers that help predict how patients respond to treatment. A recurring theme in recent work is how socioeconomic factors and healthcare access affect who receives comprehensive cancer treatment. This work is relevant to students interested in translational and clinical oncology research, particularly around treatment decision-making and disparities in cancer care.

Pancreatic cancer treatment and surgeryNeoadjuvant therapy and treatment response predictionCancer biomarkers (e.g., CA19-9, genetic alterations)Socioeconomic disparities in cancer careRadiation therapy planning and staging for pancreatic cancer

Publication output has been modest but fairly steady over the past decade, with a noticeable increase in the last three years (2023-2025).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 1 publication172018: 1 publication182019: 2 publications192020: 1 publication202021: 1 publication21222023: 2 publications232024: 2 publications242025: 3 publications32526
Recent publications
Publishes in
  • Gastroenterology×4
  • Journal of Clinical Oncology×2
  • International Journal of Radiation Oncology*Biology*Physics×1
  • Frontiers in Oncology×1
  • PLoS ONE×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile